Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?

Rheumatology

Volumn 39, Issue 10, 2000, Pages 1102-1109

  Griffith, S M ^a   Fisher, J ^b   Clarke, S ^b   Montgomery, B ^b   Jones, P W ^c   Saklatvala, J ^b   Dawes, P T ^b   Shadforth, M F ^b   Hothersall, T E ^b   Hassell, A B ^b   Hay, E M ^b  

^a EAST SURREY HOSPITAL   (United Kingdom)

^b Staffordshire Rheumatology Centre   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

Author keywords

Folic acid; Methotrexate

Indexed keywords

FOLIC ACID; METHOTREXATE; PLACEBO;

ADULT; AGED; ANKLE EDEMA; ARTHROPATHY; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRY EYE; DYSPEPSIA; FATIGUE; FEMALE; FEVER; HEADACHE; HEART PALPITATION; HEMATURIA; HUMAN; INDIGESTION; KIDNEY DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NAUSEA; NEUTROPENIA; OLIGOPHRENIA; OTALGIA; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS; SEPSIS; SORE THROAT; STOMACH PAIN; TREATMENT OUTCOME; UNITED KINGDOM; URINARY TRACT INFECTION; VERTIGO; VISUAL DISORDER; VITAMIN SUPPLEMENTATION; VOMITING; XEROSTOMIA;

EID: 0033783023     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.10.1102     Document Type: Article

References (28)

1. Serious problems with methotrexate?
2. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis
3. Radiographic evidence of disease progression in methotrexate treated and non methotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients
4. Methotrexate in rheumatoid arthritis: An update
5. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis
6. Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate
7. Elevated mean corpuscular volume as a predictor of haematologic toxicity due to methotrexate therapy
8. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis
9. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A meta-analysis of randomized controlled trials
10. Folate supplementation and methotrexate
11. The choice of a balanced allocation method for a clinical trial of otitis media with and effusion
12. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
13. 4,500 years of drug monitoring at the Staffordshire Rheumatology Centre (SRC)-clinical experience and the patient database
14. Assessment of patient satisfaction with activities of daily living using a modified Stanford Health Assessment Questionnaire
15. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
16. Small joint synovitis in rheumatoid arthritis: Should it be assessed separately?
17. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films
18. The hospital anxiety and depression scale
19. Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis
20. Methotrexate in rheumatoid arthritis: An update with focus on mechanisms involved in toxicity
21. Molecular therapeutics. Methotrexate and its mechanism of action
22. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: Association with hepatic folate deficiency and formation of polyglutamates
23. Pancytopenia associated with low dose methotrexate therapy. A regional survey
24. Folate supplementation in methotrexate-treated rheumatoid arthritis patients
25. Molecular and cellular effects of methotrexate
26. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis
27. Effects of second line drugs on progression of subcutaneous rheumatoid nodules
28. Possible efficacy of hydroxychloroquine on accelerated nodulosis during methotrexate therapy for rheumatoid arthritis